Literature DB >> 26728363

The effects of hypoxia and serum-free conditions on the stemness properties of human adipose-derived stem cells.

Wan Kamarul Zaman Wan Safwani1, Chin Wei Wong2, Kar Wey Yong2, Jane Ru Choi2, Noor Azmi Mat Adenan3, Siti Zawiah Omar3, Wan Abu Bakar Wan Abas2, Belinda Pingguan-Murphy2.   

Abstract

The need to have a better and safer culture condition for expansion of human mesenchymal stem cells (MSCs) is crucial particularly to prevent infection and immune rejection. This is normally associated with the use of animal-based serum in the culture media for cell expansion. The aim of this study is to investigate alternative culture conditions which may provide better and safer environment for cell growth. In the present study, human adipose-derived stem cells (ASCs) at passage 3 were subjected to treatment in 4 conditions: (1) 21 % O2 with fetal bovine serum (FBS), (2) 21 % O2 without FBS, (3) 2 % O2 with FBS and (4) 2 % O2 without FBS followed by subsequent analysis of their phenotype, viability and functionality. We observed that ASCs cultured in all conditions present no significant phenotypic changes. It was found that ASCs cultured in 2 % O2 without serum showed an increase in viability and growth to a certain extent when compared to those cultured in 21 % O2 without serum. However, ASCs cultured in 2 % O2 without serum displayed a relatively low adipogenic and osteogenic potential. On the other hand, interestingly, there was a positive enhancement in chondrogenic differentiation of ASCs cultured in 21 % O2 without serum. Our findings suggest that different culture conditions may be suitable for different indications. In summary, ASCs cultured in serum-free condition can still survive, proliferate and undergo subsequent adipogenic, osteogenic and chondrogenic differentiation. Therefore, FBS is feasible to be excluded for culture of ASCs, which avoids clinical complications.

Entities:  

Keywords:  21 % O2; 2 % O2; Fetal bovine serum; Human adipose-derived stem cells; Serum-free condition

Year:  2016        PMID: 26728363      PMCID: PMC5023560          DOI: 10.1007/s10616-015-9939-9

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  44 in total

1.  Assessment of tumourigenic potential in long-term cryopreserved human adipose-derived stem cells.

Authors:  Kar Wey Yong; Wan Kamarul Zaman Wan Safwani; Feng Xu; Xiaohui Zhang; Jane Ru Choi; Wan Abu Bakar Wan Abas; Siti Zawiah Omar; Mat Adenan Noor Azmi; Kien Hui Chua; Belinda Pingguan-Murphy
Journal:  J Tissue Eng Regen Med       Date:  2016-01-12       Impact factor: 3.963

2.  Novel functions of the CD34 family.

Authors:  Julie S Nielsen; Kelly M McNagny
Journal:  J Cell Sci       Date:  2008-11-15       Impact factor: 5.285

3.  A time for restraint.

Authors:  F E Young
Journal:  Science       Date:  2000-02-25       Impact factor: 47.728

4.  Pre-culturing human adipose tissue mesenchymal stem cells under hypoxia increases their adipogenic and osteogenic differentiation potentials.

Authors:  M G Valorani; E Montelatici; A Germani; A Biddle; D D'Alessandro; R Strollo; M P Patrizi; L Lazzari; E Nye; W R Otto; P Pozzilli; M R Alison
Journal:  Cell Prolif       Date:  2012-06       Impact factor: 6.831

5.  Impact of low oxygen tension on stemness, proliferation and differentiation potential of human adipose-derived stem cells.

Authors:  Jane Ru Choi; Belinda Pingguan-Murphy; Wan Abu Bakar Wan Abas; Mat Adenan Noor Azmi; Siti Zawiah Omar; Kien Hui Chua; Wan Kamarul Zaman Wan Safwani
Journal:  Biochem Biophys Res Commun       Date:  2014-04-29       Impact factor: 3.575

6.  Potent in vitro chondrogenesis of CD105 enriched human adipose-derived stem cells.

Authors:  Ting Jiang; Wei Liu; Xiaojie Lv; Hengyun Sun; Lu Zhang; Yu Liu; Wen Jie Zhang; Yilin Cao; Guangdong Zhou
Journal:  Biomaterials       Date:  2010-02-12       Impact factor: 12.479

7.  Hypoxia inhibits the differentiation of mesenchymal stem cells into osteoblasts by activation of Notch signaling.

Authors:  Ningru Xu; Hui Liu; Feng Qu; Jun Fan; Kezheng Mao; Yi Yin; Jianheng Liu; Zhenying Geng; Yan Wang
Journal:  Exp Mol Pathol       Date:  2012-08-29       Impact factor: 3.362

8.  Prolonged hypoxia concomitant with serum deprivation induces massive human mesenchymal stem cell death.

Authors:  Esther Potier; Elisabeth Ferreira; Alain Meunier; Laurent Sedel; Delphine Logeart-Avramoglou; Hervé Petite
Journal:  Tissue Eng       Date:  2007-06

9.  Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.

Authors:  Warren L Grayson; Feng Zhao; Bruce Bunnell; Teng Ma
Journal:  Biochem Biophys Res Commun       Date:  2007-05-22       Impact factor: 3.575

10.  In situ normoxia enhances survival and proliferation rate of human adipose tissue-derived stromal cells without increasing the risk of tumourigenesis.

Authors:  Jane Ru Choi; Belinda Pingguan-Murphy; Wan Abu Bakar Wan Abas; Kar Wey Yong; Chi Tat Poon; Mat Adenan Noor Azmi; Siti Zawiah Omar; Kien Hui Chua; Feng Xu; Wan Kamarul Zaman Wan Safwani
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

View more
  9 in total

Review 1.  Effect of hypoxia on human adipose-derived mesenchymal stem cells and its potential clinical applications.

Authors:  Jane Ru Choi; Kar Wey Yong; Wan Kamarul Zaman Wan Safwani
Journal:  Cell Mol Life Sci       Date:  2017-02-21       Impact factor: 9.261

2.  The Role of Hypoxia in Improving the Therapeutic Potential of Mesenchymal Stromal Cells. A Comparative Study From Healthy Lung and Congenital Pulmonary Airway Malformations in Infants.

Authors:  Serena Silvestro; Francesca Diomede; Luigi Chiricosta; Valeria Domenica Zingale; Guya Diletta Marconi; Jacopo Pizzicannella; Andrea Valeri; Maria Antonietta Avanzini; Valeria Calcaterra; Gloria Pelizzo; Emanuela Mazzon
Journal:  Front Bioeng Biotechnol       Date:  2022-06-14

Review 3.  Impact of High-Altitude Hypoxia on Bone Defect Repair: A Review of Molecular Mechanisms and Therapeutic Implications.

Authors:  Pei Chen; Yushan Liu; Wenjing Liu; Yarong Wang; Ziyi Liu; Mingdeng Rong
Journal:  Front Med (Lausanne)       Date:  2022-05-10

4.  Paracrine Effects of Adipose-Derived Stem Cells on Matrix Stiffness-Induced Cardiac Myofibroblast Differentiation via Angiotensin II Type 1 Receptor and Smad7.

Authors:  Kar Wey Yong; Yuhui Li; Fusheng Liu; Tian Jian Lu; Wan Abu Bakar Wan Abas; Wan Kamarul Zaman Wan Safwani; Belinda Pingguan-Murphy; Yufei Ma; Feng Xu; Guoyou Huang
Journal:  Sci Rep       Date:  2016-10-05       Impact factor: 4.379

5.  Evaluation of characteristic of human turbinate derived mesenchymal stem cells cultured in the serum free media.

Authors:  Se Hwan Hwang; WeonSun Lee; Sang Hi Park; Hee Jin Lee; Sun Hwa Park; Dong Chang Lee; Mi Hyun Lim; Sang A Back; Byeong Gon Yun; Jung Ho Jeun; Jung Yeon Lim; Jun Myung Kang; Sung Won Kim
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

Review 6.  Mesenchymal Stem Cell Therapy for Ischemic Tissues.

Authors:  Kar Wey Yong; Jane Ru Choi; Mehdi Mohammadi; Alim P Mitha; Amir Sanati-Nezhad; Arindom Sen
Journal:  Stem Cells Int       Date:  2018-10-08       Impact factor: 5.443

7.  Hypoxia Rapidly Induces the Expression of Cardiomyogenic Factors in Human Adipose-Derived Adherent Stromal Cells.

Authors:  Jung-Won Choi; Hanbyeol Moon; Seung Eun Jung; Soyeon Lim; Seahyoung Lee; Il-Kwon Kim; Hoon-Bum Lee; Jiyun Lee; Byeong-Wook Song; Sang Woo Kim; Ki-Chul Hwang
Journal:  J Clin Med       Date:  2019-08-15       Impact factor: 4.241

Review 8.  Impact of Microenvironmental Changes during Degeneration on Intervertebral Disc Progenitor Cells: A Comparison with Mesenchymal Stem Cells.

Authors:  Feng-Juan Lyu
Journal:  Bioengineering (Basel)       Date:  2022-04-01

Review 9.  Articular Cartilage Aging-Potential Regenerative Capacities of Cell Manipulation and Stem Cell Therapy.

Authors:  Magdalena Krajewska-Włodarczyk; Agnieszka Owczarczyk-Saczonek; Waldemar Placek; Adam Osowski; Joanna Wojtkiewicz
Journal:  Int J Mol Sci       Date:  2018-02-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.